Oncology PracticeMuscle loss during chemotherapy predicts poor survival in metastatic colorectal cancerFebruary 22, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeSIRT plus FOLFOX chemo for mCRC improved progression-free survival in liver onlyFebruary 22, 2016GastroenterologyGastrointestinal Cancer
The Journal of Community and Supportive OncologyNew GI therapies bring hope after much frustration February 21, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeNeurotoxicity tempers case for oxaliplatin in older adults with colorectal cancerFebruary 19, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeCommon medications linked to better survival in pancreatic cancerFebruary 18, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeShort sleep duration increases risk of death in patients with metastatic colorectal cancerFebruary 18, 2016GastroenterologyPatient & Survivor CareGastrointestinal Cancer
Oncology PracticeWide disparity in radiology reads without RECISTFebruary 16, 2016GastroenterologyGastrointestinal Cancer
Hematology NewsDo we give too much iron?February 10, 2016GastroenterologyAnemiaGastrointestinal Cancer
Oncology PracticeEarly mortality predicted by age and poor performance status in patients with colon cancerFebruary 8, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeMAVERICC: Search for predictive biomarkers in first-line colorectal cancer trial goes onFebruary 4, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeOffice visits still common before colonoscopyFebruary 2, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeRT for rectal cancer may reduce risk of some other cancersFebruary 1, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeSurvival of pancreatic cancer is better when adjuvant therapy is given in high-volume centersJanuary 31, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticePD-1 blockade impresses in mismatch repair–deficient GI cancersJanuary 29, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeImmune checkpoint inhibitors have antitumor activity in gastric, esophageal cancersJanuary 28, 2016GastroenterologyRenal Cell CarcinomaGastrointestinal Cancer
